Gross Profit On Sales 변화 날짜
AbbVie USD 9.56B 95M 2023-09
Abbott USD 5.68B 147M 2023-12
Amgen USD 5.08B 14M 2023-12
AstraZeneca USD 9.43B 15M 2023-09
BioCryst Pharmaceuticals USD 85.61M 4.06M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Eli Lilly USD 7.57B 73.1M 2023-12
GlaxoSmithKline GBP 5.91B 626M 2023-09
Incyte USD 949.29M 84.66M 2023-12
J&J USD 14.6B 374M 2023-12
Merck USD 11.29B 441M 2023-12
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Roche Holding CHF 22.16B 123M 2023-06
Takeda JPY 699.51B 38B 2023-09
TG Therapeutics USD 36.12M 126.19M 2023-12
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12



Karyopharm Therapeutics 판매 매출 총 이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Mar 2024.